Shire PLC is determined to get bigger, one way or another. The drug maker, which is based in Dublin and run from Lexington, on Tuesday mounted an unsolicited $30 billion bid for Baxalta Inc., a combination that could rival Biogen Inc. as the state's ...
Shire breaks cover on $30bn takeover bid for drugmaker
Shire's Offer to Buy Drug Maker Baxalta for $30 Billion Is Rebuffed
New York Times